Q2/2020 (Ending June 30, 2020) To Director and Manager of the Stock Exchange of Thailand UBIS (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial
- Translation - 13 August 2020 Subject: Management’s Discussion and Analysis for the Operating Results of the Second Quarter of 2020 Attention: The President of the Stock Exchange of Thailand Exotic
Exchange of Thailand U City Public Company Limited and its subsidiaries (the “Company”) has recently submitted the reviewed interim financial statements for the period ended 31 December 2017 to the Stock
Bangkok, April 28, 2014 ? The SEC is seeking public comment on the proposed amendments to the Securities and Exchange Act B.E. 2535 (1992) or SEA to increase competitiveness of Thai capital market in
Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the three-month period at the end of 30th September 2018 as
Microsoft Word - EKH_62-006_SET-MD&A_620225_Y61_EN EKH/CS/2020/006 27 February 2020 Subject: Management Discussion and Analysis for 2019 results To Directors and Manager The Stock Exchange of
(Translation) UAC.CS/011/2018 May 14, 2018 Subject: Explanation of the operating results for the first quarter period ended March 31, 2018 To: President The Stock Exchange of Thailand Attachment
จดหมายชี้แจงQ160e May 15, 2017 The Managing Director The Stock Exchange of Thailand Subject : Management Discussion and Analysis for three month Ending 31 March 2017 Summary of the 1 st Quarter
Letter_StockExchange_Nov14 November 14, 2019 The Managing Director The Stock Exchange of Thailand Subject : Management Discussion and Analysis for three month Ending 30 September 2019 Summary on
Attn : The Directors and The MAI Manager Ref: Dimet AC 1902/001 February 12, 2019 Attention: The Directors and The MAI Manager The Stock Exchange of Thailand Subject: Report on Q.2’s performance